Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001193125-26-382245

Chief Legal Officer sold 584 shares at $14.00 ($8,176)

  • Chief Legal Officer acquired 584 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bizily Scott · Chief Legal Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-01 Exercise or conversion : show line 1 in the form 10b5-1 +584 $6.49 $3,790 9,201 D
2026-09-01 Sale : show line 2 in the form 10b5-1 −584 $14.00 $8,176 8,617 D
Open-market sales · 584 sh · avg $14.00 · $8,176

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-01 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −584 2,959 D
Loading xslF345X06/ownership.xml…